Benzinga's Top Pre-Market Losers

Body Central

shares fell 25.33% to $11.94 in the pre-market trading. Body Central issued downbeat Q2 earnings forecast. Infinity Pharmaceuticals

dipped 22.55% to $10.75 in the pre-market session. Infinity Pharmaceuticals stopped mid-stage trials of saridegib in chondrosarcoma and myelofibrosis DSW

shares dropped 8.59% to $53.75 in pre-market trading. DSW reiterated its 2012 forecast. The company's board also authorized a new $100 million stock buyback program. Steel Dynamics

dipped 4.90% to $10.48 in the pre-market session. Steel Dynamics issued downbeat Q2 earnings forecast.